Upload
melanie-lee
View
215
Download
0
Tags:
Embed Size (px)
Citation preview
1
F314 Follow-up Clinical TrainingF314 Follow-up Clinical TrainingJanuary 23, 2006January 23, 2006
Presented by
Jeri Lundgren, RN, CWS, CWCN Wound Care Consultant
Pathway Health Services
2
Training ObjectivesTraining Objectives
Know what a comprehensive risk assessment should include
Discuss individualized turning and repositioning Understand the treatment for lower extremity
wounds Describe the causes of pressure ulcers Differentiate between pressure reduction verses
pressure relief Discuss the application of pulsatile lavage in
wound management
3
Risk AssessmentRisk Assessment
Guidance states
“Although the requirements do not mandate any specific assessment tool, other than the RAI, validated instruments are available to assess risk for developing pressure ulcers”
4
Risk Assessment ToolsRisk Assessment ToolsBRADEN SCALEBRADEN SCALE
Mobility Activity Sensory Perception Moisture Friction & Shear Nutrition
*Please note: Using the Braden scale requires obtaining permission atwww.bradenscale.com or (402) 551-8636
5
“Regardless of any resident’s total risk score, the clinicians responsibility for the resident’s care should review each risk factor and potential cause(s) individually”
“an overall risk score indicating the resident is not at high risk of developing pressure ulcers does not mean that existing risk factors or causes should be considered less important or addressed less vigorously than those factors or causes in the resident whose overall score indicates he or she is at a higher risk of developing a pressure ulcer.”
Risk Assessment ToolsRisk Assessment Tools
6
Risk Assessment ToolsRisk Assessment Tools
A COMPREHENSIVE risk assessment should be done:
– Upon admission
– *Weekly for the first four weeks after admission*
– With a change of condition
– Quarterly
7
Comprehensive Risk Comprehensive Risk AssessmentAssessment
Overall skin condition - including tissue tolerance
Medical diagnosis and co-morbidities Medications or Treatments Degree of Mobility Incontinence of Bowel and/or Bladder Scarring over bony prominences Contractures Bedfast or Chair-bound
8
Comprehensive Risk Comprehensive Risk AssessmentAssessment
Cognitively impaired Resident choice Restraints Unrelieved pain Slouching in a chair Repeated hospitalizations or ER visits
with-in 6 months Nutrition and hydration
9
Comprehensive Risk Comprehensive Risk AssessmentAssessment
The overall goal of the risk assessment is to ensure that individualized interventions are attempted to stabilize, reduce or remove the underlying risk factors
10
Prevention Interventions:Prevention Interventions:Provide appropriate pressure reduction or reliefProvide appropriate pressure reduction or relief
11
Prevention Interventions Prevention Interventions Choose appropriate pressure reducing Choose appropriate pressure reducing
surfaces while in bed and sittingsurfaces while in bed and sitting
Pressure Reduction: Is the reduction of interface pressure, not necessarily below capillary closure pressure
Pressure Relief: Is the reduction of interface pressure below capillary closure pressure
Capillary closing pressure is also individual to the resident
12
Support SurfacesSupport Surfaces There is no standardize testing or requirements
for support surfaces There is no set mandate or recommendation as
to when a specific type of support surface should be used.
Guidance states:“Appropriate support surfaces or devices should be
chosen by matching a device’s potential therapeutic benefit with the resident’s specific situation: for example, multiple ulcers, limited turning surfaces and ability to maintain position.”
13
Support SurfacesSupport Surfaces Surveyors should consider the following
pressure redistribution issues:– Static devices (e.g., solid foam or gel
mattresses) may be indicated when a resident is at risk or delayed healing. A specialized reduction cushion or surface might be used to extend the time a resident is sitting in a chair; however, the cushion does not eliminate the necessity for periodic repositioning
14
Support SurfacesSupport Surfaces pressure redistribution issues
continued:– Dynamic pressure reduction surfaces may be
helpful when:» The resident can’t assume a variety of positions
without bearing weight on a pressure ulcer» The resident completely compresses a static
device » The pressure ulcer is not healing as expected,
and it is determined that pressure may be contributing to the delay in healing
15
Prevention InterventionsPrevention Interventions
16
Support SurfacesSupport Surfaces Use of recliners, guidance states
“The care plan for a resident who is reclining and is dependent on staff for repositioning should address position changes to maintain the resident’s skin integrity.”…..”Elevating the head of the bed or the back of a reclining chair to or above a 30 degree angle creates pressure comparable to that exerted while sitting, and requires the same considerations regarding repositioning as those for a dependent resident who is seated.”
17
Support SurfacesSupport Surfaces Recliners continued
– Remember off-loading is one full minute of pressure relief
– Is the turning schedule in the best interest for the resident or per their wishes or is it in the best interest for staff
Foam vs. Gel vs. Air wheelchair cushions– Overall ensure it is the best for the individual resident
18
Prevention InterventionsPrevention Interventions Develop an INDIVIDUALIZED turning & repositioning
schedule Tissue tolerance is the ability of the skin and it’s
supporting structures to endure the effects of pressure with out adverse effects
There is no standard/mandated “Tissue Tolerance Test”
“A skin inspection should be done, which should include an evaluation of the skin integrity and tissue tolerance, after pressure to that area, has been reduced or redistributed”
19
Prevention InterventionsPrevention Interventions
After skin integrity and tissue tolerance has been assessed the resident then should be put on an appropriate INDIVIDUALZED turning and repositioning program
Ongoing monitoring of tissue tolerance and skin integrity should be done
Recommend assessing skin integrity and tissue tolerance upon admission and with a significant change of condition
20
Lower Extremity WoundsLower Extremity Wounds
• Arterial Insufficiency
• Venous Insufficiency
• Peripheral Neuropathy/Diabetic
Referred to F309 Tag
21
Arterial InsufficiencyArterial Insufficiency
22
Arterial Insufficiency UlcersArterial Insufficiency Ulcers
Location– Toe tips and/or web spaces
– Phalangeal heads around lateral malleolus
– Areas exposed to pressure or repetitive trauma (shoe, cast, brace, etc.)
23
Arterial InsufficiencyArterial Insufficiency
24
Arterial Insufficiency Arterial Insufficiency InterventionsInterventions
Measures to Improve Tissue Perfusion– Revascularization if possible
– Lifestyle changes (no tobacco, no caffeine, no constrictive garments, avoidance of cold)
– Hydration
– Measures to prevent trauma to tissues (appropriate footwear at ALL times)
– Aspirin in doses of 75-325 mg oral/day
25
Arterial Insufficiency Arterial Insufficiency InterventionsInterventions
NutritionConsider niacin; niacin has been shown to HDL-C & Triglycerides in oral dosages of 3,000mg/d
L-Arginine (vasodilator properties) oral intake of 6.6 g/day for 2 weeks improved symptoms of intermittent claudication
Provide nutritional support with 2,000 or more calories preoperatively and postoperatively, if possible; this has been benefited patients undergoing amputations
26
Arterial Insufficiency Arterial Insufficiency InterventionsInterventions
Pain ManagementRecommend walking to near maximal pain three times per week.
Administer Cilostazol, 100mg BID, orally
Topical TherapyDry uninfected necrotic wound: KEEP DRY
Dry INFECTED wound: Immediate referral for surgical debridement/aggressive antibiotic therapy (Topical antibiotics are typically in-effective for arterial wounds)
27
Arterial Insufficiency Arterial Insufficiency InterventionsInterventions
Topical Therapy (continued)Open Wounds
Moist wound healing
Non-occlusive dressings (e.g. solid hydrogel)
Aggressive treatment of any infection
Adjunctive TherapiesHyperbaric oxygen therapy
Intermittent pneumatic compression
Topical autologous activated mononuclear cells, twice per week (Autologel)
28
Arterial Insufficiency Arterial Insufficiency InterventionsInterventions
Adjunctive Therapies (continued)High-voltage pulsed current (HVPC) electrotherapy
Patient Education
29
Venous InsufficiencyVenous Insufficiency
30
Venous Insufficiency UlcersVenous Insufficiency Ulcers
Location– Medial aspect of the lower leg and ankle
– Superior to medial malleolus
31
32
Venous Insufficiency TreatmentVenous Insufficiency Treatment
Surgical obliteration of damaged veins
Elevation of legs
*Compression therapy to provide at least 30mm Hg compression at the ankle– Short stretch bandages (e.g. Setopress, Surepress)– Therapeutic support stockings– Unna’s boot– Profore layer wrap– Compression pumps
*ensure compression therapy in not contraindicated
33
Venous Insufficiency TreatmentVenous Insufficiency Treatment
Topical TherapyAbsorb exudate (e.g. alginate, foam)
Maintain moist wound surface (e.g. hydrocolloid)
Chronic or non-responding wounds:Small Intestinal SubmucosaTechnology (Oasis Wound Matrix; Healthpoint)
Bi-layered cell therapy (Apligraf; Organogenesis, Inc.)
Patient Education
Appropriate antibiotics to treat infection
34
Peripheral Neuropathy/Diabetic Peripheral Neuropathy/Diabetic Signs & SymptomsSigns & Symptoms
Relief of pain with ambulation Parasthesia of extremities Altered gait Orthopedic deformities Reflexes diminished Altered sensation (numbness, prickling,
tingling)
35
Peripheral Neuropathy/Diabetic Peripheral Neuropathy/Diabetic Signs & SymptomsSigns & Symptoms
Intolerance to touch (e.g., bed sheets touching legs)
Presence of calluses
Fissures/cracks, especially the heels
Arterial insufficiency commonly co-exists with peripheral neuropathy!
36
Peripheral NeuropathyPeripheral NeuropathyDiabetic LocationDiabetic Location
Plantar aspect of the foot Metatarsal heads Heels Altered pressure points Sites of painless trauma and/or repetitive
stress
37
38
Peripheral NeuropathyPeripheral NeuropathyDiabetic TreatmentDiabetic Treatment
Pressure relief for heal ulcers
“Offloading” for plantar ulcers (bedrest, contact casting, or orthopedic shoes)
Appropriate footwear
Tight glucose control
Aggressive infection controlorthopedic consult for exposed bone and antibiotic therapy
Zyvox – approved for MRSA
Treatment for co-existing arterial insufficiency
39
Peripheral NeuropathyPeripheral NeuropathyDiabetic TreatmentDiabetic Treatment
Topical Treatment– Cautious use of occlusive dressings– Dressings to absorb exudate– Dressings to keep dry wound moist
Chronic or non-responding wounds:– Recombinant human platelet-derived growth
factors (Regranex Gel; Johnson & Johnson)– Human fibroblast-derived dermal substitute
(Dermagraft; Smith & Nephew)– Bi-layered cell therapy (Apligraf; Organogenesis,
Inc.)
40
Peripheral NeuropathyPeripheral NeuropathyDiabetic TreatmentDiabetic Treatment
Adjunctive TherapyHyperbaric Oxygen
MIRE - nitric oxide and monochromatic infrared photo energy (Anodyne Therapy LLC, Tampa, FL)
The V.A.C (KCI)
Patient Education
41
Mixed EtiologyMixed Etiology
42
Mixed EtiologyMixed Etiology
Use reduced compression bandages of 23-30 mm Hg at the ankle. Compression therapy should not be used in patients with ABI < 0.5
Keep extremities in neutral position
Protect from trauma
Pressure UlcersPressure Ulcers
44
Pressure UlcersPressure Ulcers
45
Contributing factors: Contributing factors: FrictionFriction
46
Contributing factors: Contributing factors: FrictionFriction
47
Contributing factors: ShearContributing factors: Shear
48
Contributing factors: ShearContributing factors: Shear
49
Contributing factors: Contributing factors: MoistureMoisture
50
Contributing factors: Contributing factors: MoistureMoisture
51
Topical TreatmentTopical Treatment
Wound Debridement Removal of devitalized tissue is considered
necessary for wound healing
Exception: Stable heel ulcers with a protective
eschar covering with no signs or symptoms of
edema,erythema, fluctuance, or drainage, do NOT
need debridement
52
Wound DebridementWound Debridement
Mechanical: Use of wet-to-dry, hydrotherapy and wound irrigation to remove devitalized tissue
Disadvantage: non-selective, painful and can lead to excessive bleeding
NOTE: A wet-to-dry dressing should be used for debridement purposes ONLY
53
Wound DebridementWound Debridement
Pulsatile Lavage– It is a form of mechanical
debridement to facilitate removal of larger amounts of debris
– Irrigation pressure should not exceed 15psi
– It is best discontinued once the wound is clean
54
Pulsatile LavagePulsatile Lavage– It can cause dissemination of wound bacteria
over a wide area, exposing the resident and
care provider to potential contamination (JAMA Vol. 292 No. 24, December 22/29, 2004 & Nursing 2005, January 2005 Issue)
– Study at John Hopkins University School of Medicine, traced 11 patients infected with acinetobacter baumannii, back to the use of pulsatile lavage equipment. 3 of the patients required ICU care for sepsis and respiratory distress
55
Pulsatile LavagePulsatile Lavage– Precautions must be used
» Use continuous suction» Keep splash shield in contact with the
wound/periwound» Empty suction waste container after each
use» Dispose of all single-use pulsatile lavage
components, then sterilize or disinfect all reusable items
» Always perform pulsatile lavage in a private room enclosed with walls and doors
» Thoroughly clean and disinfect environmental surfaces
56
Pulsatile LavagePulsatile LavagePrecautions continued»Wear fluid proof gown,
mask/goggles or face shield and hair cover
»Resident should consider the use of a droplet barrier, such as a surgical mask
»Use a drape or towel to cover all resident lines, ports and wounds that aren’t being treated
57
THANK YOU!!!THANK YOU!!!Jeri Lundgren, RN, CWS,
CWCN
Wound Care Consultant
Pathway Health Services
612-805-9703